ASCO GU 2019: Gemcitabine + Axitinib Shows Promising Efficacy in Sarcomatoid Renal Cell Carcinoma

PracticeUpdate Editorial Team
Published in Oncology
News – February 20, 2019

Though confirmation is needed, gemcitabine may come to be considered a treatment option for sarcomatoid renal cell carcinoma.

Read article
No Comments

Sorry, the comment form is closed at this time.

You don't have permission to register